Sign In
Buy BNTX
$88.45
-0.690 (-0.774%)
At Close: Jun 03, 2026
Biontech announces vaccine development for Omicron variant
10:42pm, Monday, 29'th Nov 2021 PM News Nigeria
BioNTech said that the new variant is significantly different from previously observed variants because it had additional mutations on the spike protein.
BioNTech starts work on new vax to target Omicron
06:02pm, Monday, 29'th Nov 2021 New York Post
BioNTech and Pfizer are both currently conducting studies to test whether their current shot may be effective against Omicron.
BioNTech and Johnson & Johnson announce they will be working on Omicron specific COVID-19 vaccine
05:10pm, Monday, 29'th Nov 2021 Daily Mail Online
Both BioNTech and J&J announced Monday morning they are working on vaccines specific to fighting the Omicron variant, which was discovered last week in South Africa.
Why BioNTech Is Beating the Market Today
04:37pm, Monday, 29'th Nov 2021
The company is getting a quick start on heading off a potential major global health threat.
COVID-19: Biontech announces development of adapted vaccine for Omicron variant
04:17pm, Monday, 29'th Nov 2021 Vanguard Nigeria
The German vaccine manufacturer, Biontech, has announced that it is developing an adapted vaccine. The vaccine is to serve as a precautionary measure while simultaneously The post COVID-19: Biontech announces development of adapted vaccine for Omicron variant appeared first on Vanguard News .
Covid could become like the flu, creating opportunities in science, says Cantor's Alethia Young
04:16pm, Monday, 29'th Nov 2021
Alethia Young, senior biotech analyst at Cantor Fitzgerald, joins 'Closing Bell' to discuss the impact of the omicron variant on the overall biotech sector.
BioNTech works on its answer to new Covid variant
03:38pm, Monday, 29'th Nov 2021 Russia Today
German biotech firm BioNTech has said it has started work on an altered vaccine to fight the Omicron variant of Covid-19, which has significant mutations which may allow it to bypass the protection offered by current jabs. Read Full Article at RT.com
Omicron Fears Fuel Rally in Vaccine Stocks: Will It Continue?
03:23pm, Monday, 29'th Nov 2021
Another variant of the coronavirus, Omicron, is up on the WHO-identified list. Several mutations of this variant spark fears of high resistance to the COVID-19 vaccines.
News24.com | Omicron variant: Pfizer partner can have a vaccine ready in 100 days
02:43pm, Monday, 29'th Nov 2021 News24
BioNTech and Moderna are working to adapt their Covid-19 vaccines to address the omicron variant, with the German partner of Pfizer saying it could have a new version ready within 100 days if necessary.
Covid -19 vaccine makers start work on Omicron-tailored shots
02:33pm, Monday, 29'th Nov 2021 Cyprus Mail
BioNTech, Moderna and Johnson & Johnson are working on vaccines that specifically target Omicron in case their existing shots are not effective against the new coronavirus variant, the companies said on Monday. The variants emergence has triggered a strong global response as countries worried that it could spread fast even
Thinking about trading options or stock in Li Auto, BioNTech, Callon Petroleum, Boeing, or Apple?
02:31pm, Monday, 29'th Nov 2021 Benzinga
NEW YORK , Nov. 29, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for LI, BNTX, CPE, BA, and AAPL. … Full story available on Benzinga.com
BioNTech starts work on Omicron-specific COVID-19 vaccine
02:17pm, Monday, 29'th Nov 2021 Channel NewsAsia
BioNTech working to adapt its Covid-19 vaccine for Omicron variant
01:51pm, Monday, 29'th Nov 2021 BusinessLIVE
BioNTech SE is working to adapt its Covid-19 vaccine to address the omicron variant and expects to have a new version ready within 100 days if necessary.
Carnival Will Survive the Latest Covid-19 Variant Omicron
01:46pm, Monday, 29'th Nov 2021
Carnival will survive the effects of the latest Covid-19 variant Omicron. CCL stock is a great buy here even being extremely conservative, putting Carnival's value at $24 per share or 34% over today.
5 Vaccine Stocks to Watch as New Covid-19 Variant Strikes the Market
01:19pm, Monday, 29'th Nov 2021
The omicron variant dealt the stock market a blow, but these vaccine stocks promise investors a way to cash in while combatting Covid-19. The post 5 Vaccine Stocks to Watch as New Covid-19 Variant Str
